Impact of gliclazide on DNA damage and repair in type 2 diabetic patients - a preliminary report

被引：0
|
作者：
Drzewoski, J.
Sliwinska, A.
Blasiak, J.
Kasznicki, J.
机构：
[1] Med Univ Lodz, Dept Internal Dis Diabetol & Clin Pharmacol, Zgierz, Poland
[2] Univ Lodz, Dept Mol Genet, PL-90131 Lodz, Poland
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0876
引用
收藏
页码：S361 / S362
页数：2
相关论文
共 50 条
  • [21] Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report.
    Feola, M.
    Pastorini, G.
    Anastasio, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] Association of KCNQ1 polymorphisms with gliclazide efficacy in Chinese type 2 diabetic patients
    Duan, Fangfang
    Guo, Yali
    Zhang, Liuwei
    Chen, Peixian
    Wang, Xiaozhu
    Liu, Zhike
    Hu, Yonghua
    Chen, Shenren
    Chen, Dafang
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (04): : 178 - 183
  • [23] Does insulin treatment affect fibrinogen concentration in Type 2 diabetic patients ? (Preliminary report)
    Antonopoulos, AP
    Pavlopoulos, C
    Manti, C
    Trikka, E
    DIABETOLOGIA, 2000, 43 : A204 - A204
  • [24] Effects of gliclazide on platelet aggregation and plasminogen activator inhibitor Type 1 level in Type 2 diabetic patients
    Konya, H
    Hamaguchi, T
    Satani, K
    Umehara, A
    Ishikawa, T
    Kohri, K
    Hasegawa, Y
    Suehiro, A
    Kakishita, E
    Namba, M
    DIABETOLOGIA, 2004, 47 : A253 - A253
  • [25] Modulatory effect or gliclazide on cytokine production in type II diabetic patients
    Desfaits, AC
    Serri, O
    Renier, G
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 274 - 274
  • [26] DNA damage repair genes as modifiers of clinical outcomes in Cuban patients with Spinocerebellar Ataxia type 2
    Almaguer-Mederos, Luis
    Cuello-Almarales, Dany
    Aguilera-Rodriguez, Raul
    Almaguer-Gotay, Dennis
    Gonzalez-Zaldivar, Yanetza
    Gispert-Sanchez, Suzana
    Auburger, Georg W. J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1493 - 1493
  • [27] OZONE THERAPY IN TYPE 2 DIABETIC ERECTILE DYSFUNCTION (A PRELIMINARY REPORT)
    Pranata, Mulyadi Tedja
    JOURNAL OF MENS HEALTH, 2010, 7 (03) : 319 - 320
  • [28] Gliclazide alone or in combination with atorvastatin ameliorated reproductive damage in streptozotocin-induced type 2 diabetic male rats
    Oztas, Ezgi
    Yilmaz, Tugba Ekiz
    Guzel, Elif
    Sezer, Zehra
    Okyar, Alper
    Ozhan, Gul
    SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (03) : 422 - 431
  • [29] Different effects of glibenclamide and gliclazide on forearm vascular reserve in Type-2 diabetic patients.
    Wascher, TC
    Boes, U
    DIABETOLOGIA, 2002, 45 : A275 - A275
  • [30] Oxidative protein damage in plasma of type 2 diabetic patients
    Telci, A
    Çakatay, U
    Kayali, R
    Erdogan, C
    Orhan, Y
    Sivas, A
    Akçay, T
    HORMONE AND METABOLIC RESEARCH, 2000, 32 (01) : 40 - 43
12345